Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Contact Us
Career
Josef Neu, M.D.
May 23, 2018
Latest press releases
2025-12-11 18:05
Infant Bacterial Therapeutics secures partnership with BioConnection for production of Drug Product
2025-11-25 18:41
IBT changes the IBP-9414 pathway for approval following discussions with the FDA
Regulatory
MAR
2025-11-20 16:42
Infant Bacterial Therapeutics AB secures partnership with Recipharm Advanced Bio for production of drug substance
2025-11-13 07:30
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – September 30, 2025
Regulatory
2025-10-20 10:35
Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2026
Regulatory